No Data
No Data
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Ascendis Pharma Initiated at Buy by UBS
Ascendis Pharma Analyst Ratings
UBS Initiates Ascendis Pharma A/S(ASND.US) With Buy Rating, Announces Target Price $196
BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $203
Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference